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Distinct Narcolepsy Syndromes in Orexin Receptor-2
and Orexin Null Mice: Molecular Genetic Dissection
of Non-REM and REM Sleep Regulatory Processes
Introduction
Appropriate control of brain activity states permits the
expression of behaviors that are critical for adaptation
and survival. Neurobehavioral states in mammals reveal
a characteristic architecture of alternating wakefulness,
rapid eye movement (REM) sleep, and non-REM sleep
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(Jones, 1998). Wakefulness is characterized by full con-and Masashi Yanagisawa1,6,10,*
sciousness, high muscle tone, and cortical activation1 Department of Molecular Genetics
with electroencephalographic (EEG) waveforms of low2 Department of Pediatrics
amplitude and mixed frequency. It is associated with3 Department of Internal Medicine
high neuronal activity of specific monoaminergic and4 Department of Pathology
cholinergic structures in the basal forebrain, hypothala-5 Department of Biochemistry and
mus, and brainstem (McGinty and Szymusiak, 2001;6 Howard Hughes Medical Institute
Saper et al., 2001; Steriade and McCarley, 1990). De-University of Texas Southwestern
creased activity of this system and increased activityMedical Center at Dallas
in the ventral lateral preoptic hypothalamus (VLPO) isDallas, Texas 75390
associated with gradual progression from wakefulness7 Departments of Neurology and Medicine
to non-REM sleep, which is accompanied by reducedDivision of Endocrinology
mental activity and responsiveness to environmentalBeth Israel Deaconess Medical Center and
stimuli, reduced muscle tone, and synchronized thala-8 Program in Neuroscience
mocortical activity which generates “slow waves” in theHarvard Medical School
EEG. In contrast, REM sleep, a behaviorally active state,Boston, Massachusetts 02215
normally occurs after a prolonged period of non-REM9 Department of Physiology
sleep. In addition to rapid eye movements, REM sleepNew York Medical College
is associated with atonia of postural muscles, vividValhalla, New York 10595
dreaming, and EEG rhythms of low amplitude and mixed10 ERATO Yanagisawa Orphan Receptor Project
frequency that are dominated by hippocampal thetaJapan Science and Technology Corporation
rhythms in some species. Maintenance of REM sleep isTokyo 135-0064
associated with the activity of subsets of VLPO neuronsJapan
and cholinergic and cholinoceptive neurons in the meso-
pontine tegmentum (MPT), as well as inactivity of wake-
related monoaminergic structures.Summary
Narcolepsy-cataplexy is a debilitating neurological
disorder that provides a unique perspective on theNarcolepsy-cataplexy, a neurological disorder associ-
mechanisms of sleep/wake control. The syndrome con-ated with the absence of hypothalamic orexin (hypocre-
sists of excessive daytime sleepiness accompanied bytin) neuropeptides, consists of two underlying problems:
irresistible “sleep attacks,” cataplexy (sudden bilateralinability to maintain wakefulness and intrusion of rapid
loss of postural muscle tone triggered by emotions),eye movement (REM) sleep into wakefulness. Here we
sleep-onset hallucinations, and sleep paralysis. Of thesedocument, using behavioral, electrophysiological, and
symptoms, cataplexy is the most specific marker of the
pharmacological criteria, two distinct classes of be-
syndrome in humans (Aldrich, 1998). These symptoms
havioral arrests exhibited by mice deficient in orexin- are believed to result from two underlying problems: (1)
mediated signaling. Both OX2R/ and orexin/ mice inability to maintain wakefulness and (2) intrusion of
are similarly affected with behaviorally abnormal at- features of REM sleep into wakefulness or at sleep onset
tacks of non-REM sleep (“sleep attacks”) and show (Taheri et al., 2002).
similar degrees of disrupted wakefulness. In contrast, Narcolepsy-cataplexy in humans has recently been
OX2R/ mice are only mildly affected with cataplexy- recognized as resulting from the loss of hypothalamic
like attacks of REM sleep, whereas orexin/ mice are neurons containing orexin (hypocretin) neuropeptides,
severely affected. Absence of OX2Rs eliminates ore- possibly by an autoimmune process, renewing interest
xin-evoked excitation of histaminergic neurons in the in the hypothalamus as a critical participant in sleep/
hypothalamus, which gate non-REM sleep onset. wake control (Mignot et al., 2002b; Saper et al., 2001;
While normal regulation of wake/non-REM sleep tran- Sutcliffe and de Lecea, 2002; Willie et al., 2001). The
sitions depends critically upon OX2R activation, the neuropeptides orexin-A and orexin-B are products of
profound dysregulation of REM sleep control unique the prepro-orexin (prepro-hypocretin) gene (de Lecea
to the narcolepsy-cataplexy syndrome emerges from et al., 1998; Sakurai et al., 1998). Orexins are produced
loss of signaling through both OX2R-dependent and exclusively by a population of neurons in the lateral
OX2R-independent pathways. hypothalamic area (LHA). The LHA is a region classically
implicated in energy homeostasis, autonomic tone, and
motivated behavior. Notably, orexin neurons send projec-*Correspondence: masashi.yanagisawa@utsouthwestern.edu
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tions throughout the brain and spinal cord with particularly from the vast majority of human narcolepsy cases in
which orexin peptides are lacking.dense innervations of monoaminergic and cholinergic
centers controlling sleep/wakefulness in the hypothala- In this study, we systematically compared the pheno-
types resulting from OX2R- and orexin-deficient statesmus and brainstem (Chemelli et al., 1999; Peyron et al.,
1998). A number of studies have suggested that orexin in mice (orexin/ and OX2R/ mice). We used histologi-
cal methods and intracellular calcium imaging of brainpeptides are primarily neuroexcitatory (Sutcliffe and de
Lecea, 2002). tissue of wild-type and OX2R/ rodents to examine the
role of OX2Rs in orexin-mediated excitation of neuronsOrexin peptides are endogenous ligands for two G
protein-coupled receptors termed orexin receptors type of the TM. We used behavioral, pharmacological, and
electroencephalographic/electromyelographic (EEG/1 and type 2 (OX1R and OX2R) (Sakurai et al., 1998).
OX1Rs exhibit selective affinity for orexin-A, while EMG) methods to compare symptoms of narcolepsy in
OX2R/ and orexin/ mice in detail.OX2Rs exhibit equal affinity for both orexin-A and ore-
xin-B. Both receptors are expressed in nuclei of the
hypothalamus and MPT as well as more widespread Results
regions of the central nervous system (Marcus et al.,
2001). The differential distribution of orexin receptors Production of OX2R Knockout Mice
suggests distinct roles of each receptor in aspects of To target the mouse OX2R gene, we constructed a tar-
vigilance state control, muscle tone, and energy homeo- geting vector to replace exon 1 in-frame with a nuclear
stasis. In particular, OX2R expression is prominent in -galactosidase (nlacZ)- and neomycin resistance (neo)-
the cerebral cortex, septal nuclei, hippocampus, medial expressing cassette by homologous recombination of
thalamic groups, raphe nuclei, and many hypothalamic linearized vector in 129/Sv embryonic stem (ES) cells
nuclei, including the histaminergic tuberomammillary (Figure 1A). Correctly targeted ES cell clones were iso-
nucleus (TM). Notably, recent studies have indicated an lated and injected into C57BL/6J blastocysts to yield
important role for histamine signaling as a downstream chimeric mice that transmitted the targeted allele
mediator of wakefulness produced by intracerebroven- through the germline. Knockout mice were genotyped
tricular (i.c.v.) administration of orexin (Huang et al., as wild-type, hetereozygous, or homozygous by PCR.
2001; Yamanaka et al., 2002). Genotyping of male and female progeny of F1 and F2
Evidence implicating the orexin system in narcolepsy- heterozygote crosses from two independent lines re-
cataplexy first came from studies in animal models. A vealed ratios consistent with Mendelian inheritance by
positional cloning approach linked autosomal recessive 2 square analysis (data not shown) and indicated that
inheritance of a narcolepsy-like syndrome in canine homozygosity did not cause significant lethality.
breeds with mutations in the OX2R gene (Lin et al., 1999). Histological studies, using H&E and Nissl staining,
Independently, knockout of the prepro-orexin gene in failed to detect any structural abnormality in the brains
mice causes a phenotype remarkably similar to the hu- of homozygous null mice. In situ hybridization of brain
man disorder: abrupt behavioral arrests with muscle sections from OX2R/ mice using a riboprobe specific
atonia, fragmented wakefulness, and direct transitions for exon 3 revealed no significant signal above back-
from wakefulness to REM sleep (Chemelli et al., 1999). ground in brain regions where OX2R is normally ex-
Mice with a selective postnatal loss of orexin-producing pressed (Figure 1B). Northern blots of whole-brain RNA
neurons have essentially identical behavioral abnormali- revealed attenuation of OX2R mRNA expression in
ties (Hara et al., 2001). Clinical studies have indicated OX2R/ mice and complete absence of signal in
that the narcolepsy-cataplexy syndrome (but not narco- OX2R/ mice. Notably, orexin mRNA expression, atten-
lepsy without cataplexy, idiopathic hypersomnolence, uated in orexin/ mice and absent in orexin/ mice,
or other sleep and neurological disorders) is associated was elevated about 2-fold in OX2R/ mice (Figure 1C).
with low or undetectable levels of orexin-A in CSF and In contrast, OX1R mRNA expression was not affected
in LHA cells, confirming the specific role that loss of by the loss of either the orexin or OX2R genes. Radioim-
orexin-producing neurons plays in this syndrome (Kan- munoassays specific for orexin-A and orexin-B on
bayashi et al., 2002; Mignot et al., 2002a; Peyron et whole-brain homogenates failed to detect significant
al., 2000; Ripley et al., 2001b; Thannickal et al., 2000). changes in the amounts of these peptides in OX2R/
Furthermore, detection of extracellular orexin peptide mice compared to wild-type mice (Figure 1D). These
levels in brains of normal animals by microdialysis indi- findings indicate that the targeted OX2R allele is func-
cates that orexin levels accumulate during wakefulness tionally null, but despite increased expression of orexin
and decline with the occurrence of sleep (Kiyashchenko mRNA, whole-brain orexin peptide levels are not im-
et al., 2002; Yoshida et al., 2001). pacted by the loss of OX2Rs.
These studies together suggest that a function of ore-
xin signaling might be to stabilize prolonged periods of Role of OX2R in Tuberomammillary Nucleus:
wakefulness by opposing homeostatic sleep propensity A Hypothalamic Arousal Center
(Saper et al., 2001). However, mechanisms by which To determine the anatomical expression of OX2R mRNA
absence of orexin signaling causes symptoms of narco- in the wake-promoting histaminergic neurons of the TM,
lepsy-cataplexy are unknown. Despite the association we performed dual-label in situ hybridization/immuno-
of OX2R mutations with narcolepsy in dogs, the differen- histochemistry in rat brain sections. Expectedly, we
tial roles of orexin receptors remain uncertain. While found adenosine deaminase-immunoreactive (ADA-IR)
this animal model has been used extensively in studies histaminergic neurons to be localized throughout the
investigating the neurochemical substrates of narco- TM. Nearly all histaminergic cells densely expressed
OX2R (Figure 2A).lepsy (Nishino and Mignot, 1997), it differs biochemically
Sleep Attacks in OX2R Knockout Mice
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Figure 1. Targeted Disruption of Mouse Ore-
xin Receptor Type 2 Gene
(A) Strategy for the OX2R gene knockout. A
partial map of a mouse genomic DNA frag-
ment containing exon 1 of the OX2R gene.
Sites for restriction enzymes: B, BamHI; E5,
EcoRV; H, HindIII; S, SacI; X, XhoI. Arrows
reflect the locations of PCR primers for geno-
typing.
(B) In situ hybridization of OX2R mRNA. Dark-
field photomicrographs show matched coro-
nal brain sections hybridized with a 33P-
labeled antisense riboprobe for OX2R exon 3.
Note the specific expression of OX2R mRNA
located in hypothalamic and brainstem nuclei
of the wild-type mouse and the absence of
signal in the OX2R/ mouse. No detectable
signal above background was generated by a
sense probe (data not shown). Guide sections
are from a mouse stereotaxic atlas (Franklin
and Paxinos, 1997). PH, posterior hypothala-
mic area; LH, lateral hypothalamic area; DTM,
dorsal tuberomammillary nucleus; VTM, ven-
tral tuberomammillary nucleus; ME, median
eminence; DR, dorsal raphe nucleus; MnR,
median raphe nucleus; Pn, pontine nuclei;
PnO, pontine reticular nucleus, oral; RtTg, re-
ticulotegmental nucleus pons; ml, medial
lemniscus; 12, hypoglossal nucleus; Sp5I,
spinal trigeminal nucleus, interpolar; Amb,
ambiguus nucleus; A1, A1 noradrenaline
cells; LRt, lateral reticular nucleus. Scale bar,
500 m.
(C) Northern blots of orexin, OX1R, OX2R, and
-actin mRNAs in brain extracts. Blots dem-
onstrate reduced and absent OX2R expres-
sion in OX2R/ and OX2R/ mice, respec-
tively, compared to wild-type controls. Orexin
expression was similarly reduced and absent
in orexin/ and orexin/ mice, respectively,
but was slightly elevated in OX2R/ and
OX2R/ mice. OX1R expression was not im-
pacted by the loss of either the orexin or
OX2R genes.
(D) Orexin-A- and orexin-B-specific radioim-
munoassays of brain extracts. The graphs
show the means and standard errors of
means (SEM) for the amount of orexin pep-
tides per gram of wet brain weight from six
mice of each genotype. No significant differ-
ence in orexin peptide levels among geno-
types was detected by one-way ANOVA.
Disruption of OX2R exon 1 with in-frame insertion of in TM cells from OX2R/ mice (0/61). Nevertheless, ap-
plication of glutamate elicited substantial elevation ofnLacZ resulted in nuclear expression of -galactosidase
in an OX2R gene-specific distribution in the brains of [Ca2]i in the OX2R/ cells (52/52), indicating that they
remained viable. These data demonstrated the impor-mice carrying the targeted allele. Nuclear -galactosi-
dase staining colocalized with ADA-IR of soma in the tance of OX2Rs in orexin-mediated excitation of neurons
of the TM, a structure implicated in direct and indirectTM to reveal specific expression of the targeted allele
in histaminergic cells of adult OX2R/ mice (Figure 2B), cortical activation and generation of wakefulness by
suppression of non-REM sleep (Lin et al., 1996).suggesting that these neurons develop normally.
Next we examined the role of OX2R in orexin-A-
evoked intracellular calcium transients ([Ca2]i) in the Characterization of Two Classes
of Behavioral ArrestsTM by imaging brain slices loaded with the calcium-
sensitive dye fura-2 (Figures 2C and 2D). Orexin-A (300 Behavioral arrests characteristic of narcoleptic mice are
observed frequently during the dark phase, when micenM) consistently elevated [Ca2]i in TM cells from normal
mice (35/45) but failed to elicit detectable [Ca2]i rises are most active (Chemelli et al., 1999; Hara et al., 2001).
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Figure 2. Role of OX2R in Histaminergic Tuberomammillary Nucleus
(A) Colocalization of OX2R mRNA expression (black granules from in situ hybridization) with histaminergic neurons (brown ADA-IR cell bodies)
in TM of normal rat. Bright-field color photomicrographs illustrate dense and specific colocalization. Scale bar, 30 m.
(B) Colocalization of nuclear -galactosidase stain (dark blue) with ADA-IR histaminergic soma (brown) in TM of OX2R/ mouse. Such neurons
are found in adult TM despite the absence of functional OX2Rs. Scale bar, 15 m.
(C1 and D1) Fluorescence images of fura-2-labeled cells in the TM of wild-type (C1) and OX2R/ (D1) mice. Scale bar, 30 m.
(C2 and D2) Optical signals (F/F%) reflecting [Ca2]I obtained from designated cells and several others in the same slices are shown in C2
and D2 following application of orexin-A (300 nM). Orexin produced large increases in [Ca2]i in most TM cells from control mice (C2). No
detectable orexin responses were observed in TM cells from OX2R/ mice (D2).
(D3) Responses to glutamate application of OX2R/ cells shown in (D2), indicating their viability.
These episodes in narcoleptic orexin/ mice have been We refer to these two distinct types of behavioral arrests
as “abrupt” and “gradual” arrests throughout this report.characterized previously using the following criteria: (1)
an abrupt cessation of purposeful motor activity; (2) a We characterized the behavioral arrests of male mice
of mixed genetic background (12–13 weeks of age) elic-sustained postural collapse maintained throughout the
episode; and (3) an abrupt end to the episode, with ited during exploration of standard open field arenas.
Fourteen OX2R/, 12 orexin/, and 20 wild-type lit-resumption of purposeful motor activity. Preliminary
screening of OX2R/ mice during the dark phase by termates were filmed for 4 hr each from the onset of
dark phase, and video records were scored by observersinfrared video photography only rarely identified behav-
ioral arrests that fulfilled these strict requirements (Fig- blinded to genotype. No behavioral arrests of any kind
were observed in the records of wild-type mice. All ho-ure 3A and Supplemental Movies at http://www.neuron.
org/cgi/content/full/38/5/715/DC1). Instead, examina- mozygous knockout mice exhibited some form of arrest,
with the exception of two OX2R/ mice (Figures 3C andtion of OX2R/ mice revealed the occurrence of a dis-
tinct variety of behavioral arrests with onsets that were 3D). In general, mutant mice of both groups exhibited
variability in the frequency of arrests, highlighting in partmore gradual in nature (Figure 3B and Supplemental
Movies at http://www.neuron.org/cgi/content/full/38/5/ the possible influence of mixed genetic background. In
contrast to orexin/ mice, all of which exhibited abrupt715/DC1) than those typically observed in orexin/
mice. Such gradual arrests typically began during quiet arrests, only about half of the OX2R/ mice exhibited
abrupt arrests. Notably, despite similar mean durationswakefulness (see below) and could be easily distin-
guished from the normal onset of resting behavior by of abrupt arrests, orexin/ mice displayed a 31-fold
higher mean frequency of abrupt arrests per mouse than(1) the absence of stereotypic preparation for sleep (e.g.,
nesting and/or assumption of a curled or hunched pos- did OX2R/ mice (p  0.0048). As a result, total time
consumed by abrupt arrests was much greater inture, with limbs drawn under the body) and (2) a charac-
teristic ratchet-like “nodding” of the head over a period orexin/ mice in this experiment (p  0.0021).
In contrast, similar proportions of orexin/ andof several seconds, with a transition to a collapsed pos-
ture. We therefore adopted these different criteria for OX2R/ mice exhibited gradual arrests, the frequency
of which varied widely in individuals of each group (Fig-judging onset of this type of behavioral arrest, but we
maintained requirements for sustained postural change ure 3D). Overall, gradual arrests affected both genotypes
with similar frequency, but the mean duration of arrestsand abrupt termination (see Experimental Procedures).
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in orexin/ mice was longer than in OX2R/ mice (p  current EEG/EMG/video recording in electrode-implanted
animals. About 80% (61/76) of abrupt arrests in orexin/0.0034).
mice and 40% (4/10) in OX2R/ mice were accompaniedTo seek insight into the emotional states that may
by a rapid transition from wakefulness to an EEG patternprecede arrests, we categorized normal specific behav-
indistinguishable from normal REM sleep with atoniaiors immediately (5 s) prior to arrests in a manner
(Figure 4A, Table 1, and Supplemental Movies at http://similar to that previously reported (Chemelli et al., 1999).
www.neuron.org/cgi/content/full/38/5/715/DC1). Spec-Abrupt arrests in both orexin/ and OX2R/ mice were
tral analysis of EEG during abrupt arrests in orexin/highly associated with “emotive” motor activity, such
and OX2R/ mice by fast Fourier transform (FFT) re-as vigorous grooming (video supplement to Figure 3A),
vealed that the microarchitecture of the EEG duringambulation (video supplement to Figure 4A), and climb-
these episodes appeared normal, without any evidenceing; very few abrupt arrests were preceded by less con-
of seizure-related activity. EEG spectral patterns duringspicuous behaviors, including quiet wakefulness (Sup-
abrupt arrests in orexin/ mice confirmed strong corre-plemental Tables S1 and S2 at http://www.neuron.org/
lation with normal REM sleep (r  0.987) rather thancgi/content/full/38/5/715/DC1). In contrast, gradual ar-
with non-REM sleep (r  0.623) or wakefulness (r rests in both genotypes were most commonly preceded
0.744) (Figure 4D). Similar spectral patterns were ob-by quiet wakefulness (Supplemental Tables S3 and S4
served from the much smaller sample of REM sleep-and video supplement to Figure 3B at http://www.
like abrupt arrests in OX2R/ mice (r 0.989 comparedneuron.org/cgi/content/full/38/5/715/DC1). Although am-
to REM sleep, r  0.687 compared to non-REM sleep,bulation was associated with a smaller number of grad-
and r 0.722 compared to wakefulness). The remainingual arrests, only very rarely were such arrests preceded
20% (15/76) of abrupt arrests observed in orexin/ miceby vigorous grooming. In addition, gait disturbances, a
and 60% (6/10) in OX2R/ mice resembled EEG patternspossible indicator of partial cataplexy (Chemelli et al.,
of mouse non-REM sleep in the pre-REM stage (high-1999), were exclusively associated with orexin/ mice
amplitude spindle oscillations superimposed on a non-in this study and immediately preceded 42% (98/235)
REM sleep background) with atonia in the EMG (Tableof abrupt arrests in these mice. Gait disturbances never
1). EEG power spectra from such episodes exhibitedpreceded the gradual arrests in either genotype (0/56
lower correlations with REM sleep (r 0.843 in orexin/in orexin/ mice and 0/70 in OX2R/ mice.
mice, r  0.955 in OX2R/ mice), non-REM sleep (r 
0.819 in orexin/ mice, r  0.747 in OX2R/ mice), andPharmacological Responses
wakefulness (r  0.596 in orexin/ mice, r  0.833 inof Behavioral Arrests
OX2R/ mice).To probe in murine models the effects of drugs that are
In contrast, EEG/EMG correlates of gradual arrests inused in the treatment of human narcolepsy-cataplexy
orexin/ and OX2R/ mice invariably revealed the onset(Aldrich, 1998; Honda, 1988; Shneerson, 2000), matched
of attenuated muscle tone, but not atonia, and an EEGcohorts of orexin/ and OX2R/ mice were treated with
transition from wakefulness to non-REM sleep (Figuresdoses of caffeine and clomipramine. Over a dose range
4B and 4C and Table 1; Supplemental Movies at http://reported to increase wakefulness in mice (Wisor et al.,
www.neuron.org/cgi/content/full/38/5/715/DC1). In2001), the psychostimulant caffeine dose-dependently
orexin/ mice, 38% (20/53) of gradual arrests initiatedsuppressed gradual arrests (Figure 3E) as well as normal
with non-REM sleep but progressed rapidly to REMresting behavior (data not shown) in mutant mice. Similar
sleep with a latency of less than 1 min. Notably, gradualresults were achieved in both genotypes. Rather than
arrests recorded in OX2R/ mice correlated exclusively
inhibiting abrupt arrests, caffeine tended to produce a
(40/40) with characteristics of non-REM sleep. FFT anal-
mild exacerbation of abrupt arrest frequency in both
ysis confirmed that the EEG spectra during the non-
knockout strains, but these changes did not reach statis- REM phase of gradual arrests conformed to those of
tical significance. normal non-REM sleep in both orexin/ and OX2R/
In contrast to caffeine, the anticataplectic agent clom- mice (Figure 4D).
ipramine, administered at a dose reported to suppress Unexpectedly, we also observed that gradual arrests
REM sleep without altering motor activity in mice were occasionally accompanied by apparent automatic
(Eschalier et al., 1988; Kitahama and Valatx, 1980), de- behavior (continuation of semipurposeful motor activi-
creased the frequency of abrupt arrests in orexin/ mice ties after the onset of light sleep) in this experiment (Figure
compared to vehicle control without affecting the fre- 4E and Supplemental Movies at http://www.neuron.org/
quency of gradual arrests in these mice. Due to the low cgi/content/full/38/5/715/DC1). Both orexin/ and
baseline frequency of abrupt arrests in OX2R/ mice, OX2R/ mice but not wild-type mice exhibited such
no effect of clomipramine was observed on behavioral dissociated states in which stereotypic chewing of food
arrests in these mice when administered alone. Impor- continued after the onset of non-REM sleep as judged
tantly, simultaneous administration of both caffeine and by EEG/EMG. Although the brevity of many episodes
clomipramine resulted in suppression of both arrest (typically less than 10 s) precluded detailed analysis, a
types in orexin/ mice, suggesting that the effects of particularly long (42 s) episode demonstrates that the
these agents upon arrests are independent. EEG features of this example conform unambiguously
to the spectral features of non-REM sleep.
EEG/EMG Correlates of Behavioral Arrests
Cerebral cortical activity and postural muscle tone, Dysregulation of Non-REM versus REM
monitored by EEG/EMG, are useful for discriminating Sleep Transitions
sleep/wake abnormalities. To examine vigilance states Narcolepsy-cataplexy is characterized by abnormalities
in the frequencies, durations, and amounts of vigilanceduring abrupt and gradual arrests, we performed con-
Neuron
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Figure 3. Comparison of Behavioral Arrests in Knockout Mice by Infrared Videophotography
(A) Time-lapse images portraying an abrupt arrest, rarely observed in an OX2R/ mouse. Note the collapsed posture in the second panel.
View video footage of the entire arrest at http://www.neuron.org/cgi/content/full/38/5/715/DC1.
(B) Time-lapse images portraying a gradual arrest in an OX2R/ mouse. “Nodding” behavior (second panel) occurs just prior to postural
collapse (third panel). View video footage of entire arrest at http://www.neuron.org/cgi/content/full/38/5/715/DC1.
(C) Behavior of typical orexin/ and OX2R/ knockout mice during the first 4 hr of the dark phase. Durations of individual behavioral arrests
Sleep Attacks in OX2R Knockout Mice
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states over the 24 hr day. These abnormalities indicate REM sleep. Orexin/ mice exhibited a striking 75% in-
crease in the amount of time in REM sleep (p  0.0002)instability of sleep/wake states that include more fre-
quent waking during the rest phase, inability to maintain over the entire dark phase (Figure 5C and Supplemental
Table S5 at http://www.neuron.org/cgi/content/full/38/wakefulness during the active phase, and intrusions of
REM sleep into wakefulness or at sleep onset. To com- 5/715/DC1). Hourly plots of the amounts and durations
of REM sleep illustrate abnormalities of REM sleep thatpare such abnormalities in orexin/, OX2R/, and wild-
type littermate mice, we examined spontaneous sleep/ peak during the early part of the dark phase in orexin/
compared to OX2R/ and wild-type mice (Figures 5Cwake patterns by concurrent EEG/EMG recording of
electrode-implanted mice in home cages. Results ob- and 5D). Only orexin/ mice showed significant alter-
ations in the circadian frequencies of REM sleep epi-tained from wild-type mice (Figure 5 and Supplemental
Table S5 at http://www.neuron.org/cgi/content/full/38/ sodes: an increase over the entire dark phase (p 0.012)
and a compensatory reduction during the light phase5/715/DC1) closely resemble parameters previously
published for C57BL/6, 129Sv, and C57BL/6J-129SvEv (p  0.017). Only orexin/ mice had a reduced mean
interval between REM sleep episodes during the darkhybrid strains (Chemelli et al., 1999; Parmentier et al.,
2002; Tafti et al., 1997). phase (p  0.028; Supplemental Table S5 at http://
www.neuron.org/cgi/content/full/38/5/715/DC1) andInability to maintain sleep and wakefulness is indi-
cated in rodents by increased fragmentation of vigilance reduced latencies to REM sleep during both phases
(dark, p 0.0002; light, p 0.0069). While in comparisonstates. Such fragmentation is illustrated by hypnograms
of orexin/ and OX2R/ mice (Figure 5A). Indeed, fea- to orexin/ and wild-type mice OX2R/ mice tended
to exhibit intermediate values for some of these sametures of wakefulness and non-REM sleep were disrupted
to a similar degree in both genotypes. Compared to parameters of REM sleep, only a reduced REM sleep
latency during the dark phase differed significantly fromwild-type controls, both knockout groups exhibited sta-
tistically insignificant tendencies toward reduced amounts wild-type mice (p  0.0006; Figure 5 and Supplemental
Table S5 at http://www.neuron.org/cgi/content/full/38/of awake and increased amounts of non-REM sleep
during the dark phase (Figure 5C and Supplemental Ta- 5/715/DC1). Indeed, REM sleep amounts of OX2R/
mice were significantly less than those of orexin/ miceble S5 at http://www.neuron.org/cgi/content/full/38/5/
715/DC1). More importantly, both orexin/ and OX2R/ over the dark phase (p  0.0076).
Unlike wild-type mice, all orexin/ mice displayed themice exhibited higher frequencies of awake episodes
during the light (p  0.044 and p 0.0050, respectively) hallmark of rodent narcolepsy, spontaneous transitions
from the waking state directly to REM sleep, on everyand dark (p  0.0002 and p  0.0002, respectively)
phases as well as higher frequencies of non-REM sleep day of recording, without exception (Figure 5B). Such
spontaneous transitions were far less frequent or com-episodes during the dark phase (p  0.0013 and p 
0.0006, respectively). pletely absent during the same period in individual
OX2R/ mice. Overall, the mean frequency of spontane-To further characterize the fragmentation of vigilance
states, we plotted the hourly mean durations of each ously occurring transitions from awake to REM sleep
during each 24 hr period was 13-fold greater in orexin/state. Importantly, episode durations of wakefulness in
orexin/ and OX2R/ mice were severely diminished mice compared to OX2R/ mice (p  0.010). With re-
spect to the characteristics of REM sleep, OX2R/ mice(p  0.037 and p  0.0015, respectively) compared to
wild-type mice over the entire dark phase (Figure 5D). displayed an intermediate phenotype at most, with sta-
tistically insignificant changes in most parameters ofIn fact, throughout most of the dark phase, orexin/
and OX2R/ mice retained reduced hourly durations REM sleep compared to wild-type mice. Overall, the
general patterns of REM sleep amounts and durationscharacteristic of the light phase among all genotypes.
Fragmentation of vigilance patterns is also indicated by of OX2R/ mice more closely resemble those of wild-
type mice than those of orexin-deficient mice.the consistently reduced durations of non-REM sleep in
mutant strains, especially at night (orexin/, p 0.0007;
OX2R/, p  0.0020). These results demonstrate that Discussion
neither orexin/ nor OX2R/ mice are able to maintain
long bouts of wakefulness or non-REM sleep, especially Based on features of observed behavior, EEG/EMG, and
pharmacological responses, we discriminated at leastduring the active phase. Overall, with respect to parame-
ters of wakefulness and non-REM sleep, orexin/ and two distinct forms of behavioral arrest in narcoleptic
mice. We believe these arrests to be analogous to cata-OX2R/ mice are indistinguishable.
In contrast, orexin/ and OX2R/ mice are distinct plexy and sleep attacks observed in narcoleptic pa-
tients. We demonstrated that orexin/ and OX2R/from each other in the expression of abnormalities of
and occurrence over time from onset of dark phase are portrayed. Abrupt and gradual behavioral arrests are shown as upward solid and
downward gray deflections along the y-axis, respectively.
(D) Arrest frequencies of orexin/ compared to OX2R/ mice during the first 4 hr of the dark phase. Bars represent arrest counts recorded
for each mouse, with abrupt and gradual arrests shown as upward solid and downward gray bars, respectively. Insets display frequencies,
durations, and total times of arrests as means and SEM. No arrests of any kind were observed in wild-type littermate controls (data not
shown). ND, none detected; **p  0.005 compared to orexin/ mice.
(E) Suppression of behavioral arrests by antinarcoleptic drugs. Frequency of abrupt arrests (upward solid bars) and gradual arrests (downward
gray bars) in knockout mice following i.p. administration of caffeine and/or clomipramine compared to vehicle administration. *p  0.05
compared to vehicle.
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Figure 4. EEG/EMG Correlates of Two Classes of Behavioral Arrests
(A–C and E) Typical EEG/EMG traces during behavioral arrests in orexin/ and OX2R/ mice (view corresponding video footage of episodes
at http://www.neuron.org/cgi/content/full/38/5/715/DC1). Solid and gray arrows demarcate onsets and terminations of arrests, respectively.
Gray bars reflect the timing of gait disturbances and rocking behavior associated with arrests (Chemelli et al., 1999). Time and voltage scale
bars apply to all traces. Behavioral states are classified as awake, non-REM sleep, or REM sleep based on EEG/EMG features.
(A) Abrupt arrest in orexin/ mouse. Excited ambulation (high-amplitude nuchal EMG) accompanied by an EEG typical of normal active
wakefulness (low-amplitude, mixed frequency activity) gives way to rapid onset of ataxic gait, reduced neck tone, and an EEG resembling
REM sleep. Postural collapse is accompanied by neck atonia and continued REM sleep EEG. Rocking behavior from limb movement occurs
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Table 1. EEG/EMG Correlates of Behavioral Arrests Observed during Exploration of Open Field Arena
Gradual Arrests Abrupt Arrests
Orexin/ OX2R/ Orexin/ OX2R/
Non-REM sleep 33/53 (62%) 40/40 (100%) 0/76 (0%) 0/10 (0%)
Non-REM sleep  rapid 20/53 (38%) 0/40 (0%) 0/76 (0%) 0/10 (0%)
progression to REM sleepa
REM sleep 0/53 (0%) 0/40 (0%) 61/76 (80%) 4/10 (40%)
Ambiguous/pre-REM sleep 0/53 (0%) 0/40 (0%) 15/76 (20%) 6/10 (60%)
Behavioral arrests recorded from five mice of each genotype were categorized according to EEG/EMG features. No arrests were observed
in wild-type controls.
a REM sleep following non-REM sleep within less than 60 seconds after onset of arrest (see text for details).
mice exhibit an equivalent dysregulation of wakefulness waking periods with emotional content such as running,
climbing, vigorous grooming, or even social interactionand non-REM sleep. We also found that OX2Rs are
required to mediate a critical action of orexin-A on neu- (Chemelli et al., 1999), and they are specifically sup-
pressed by clomipramine. We have also occasionallyrons in the TM. In contrast, orexin/ and OX2R/ mice
differ in the expression of abnormalities of REM sleep documented apparent consciousness shortly after arrest
onset (Supplemental Movies at http://www.neuron.org/control.
cgi/content/full/38/5/715/DC1).
During REM sleep occurring in direct succession toDiscrimination of Cataplexy and Sleep Attacks
in Humans and Mice an attack of cataplexy, patients often experience sleep
paralysis and hypnagogic hallucinations. On such occa-The phenomenon of cataplexy has been conceptualized
either as a fragmentary manifestation of REM sleep or, sions, it is very difficult to differentiate transitions from
cataplexy to sleep paralysis (Hishikawa and Shimizu,alternatively, as a transitional state between wake-
fulness and REM sleep (Hishikawa and Shimizu, 1995). 1995). Because we have also observed REM sleep EEG/
EMG in succession to the onset of arrests, it is possibleAn accepted definition of cataplexy in humans includes
sudden bilateral weakness involving skeletal muscles, that a correlate of sleep paralysis may also occur in
these mice. This is consistent with the observation thatprovocation by sudden strong emotions, lack of impair-
ment of consciousness and memory, short duration (less abnormal behavioral features seen during arrests, such
as rocking or slight jerking activities, always accompanythan a few minutes), and responsiveness to treatment
with clomipramine or imipramine (Honda, 1988; Aldrich, REM sleep EEG patterns.
In contrast to cataplexy, the sleep attacks of human1998). Studies performed during cataplectic attacks
have produced conflicting results in both humans and narcolepsy are associated with impaired consciousness
and memory but not with strong emotions or abruptdogs, with some authors reporting wakefulness and oth-
ers reporting REM sleep characteristics in the EEG, de- muscle weakness. The identification of sleep attacks is
based upon a behavioral context: patients report sud-spite preservation of consciousness (Dyken et al., 1994,
1996; Guilleminault et al., 1974; Kushida et al., 1985; den irresistible sleepiness occurring during unusual cir-
cumstances (e.g., meals, conversations, driving), andMitler and Dement, 1977).
The abrupt arrests that we observed in orexin/ and such attacks may also be associated with automatic
behavior (Aldrich, 1998; Zorick et al., 1979). Sleep at-OX2R/ mice appear to fulfill criteria used for human
cataplexy. Abrupt arrests are discrete phases of pos- tacks are generally associated with the onset of early
stages of non-REM sleep, reflect a compression of thetural atonia of short duration (seconds to minutes) that
are often preceded by gait disturbances due to propa- normal process of entering sleep, and mimic the effects
of sleep deprivation in normal humans (Alloway et al.,gating atonia. Such arrests are triggered during active
exclusively during periods with EEG/EMG indistinguishable from REM sleep pattern. Residual low-amplitude noise remaining in the EMG
during atonia consists primarily of electrocardiographic contamination.
(B) Gradual arrest in OX2R/ mouse. Feeding behavior with high-amplitude EMG and a waking EEG gives way to gradual onset of postural
collapse with reduced but not atonic nuchal EMG and transition to an EEG indistinguishable from non-REM sleep. The mouse remains immobile
until sudden recovery of waking EEG and purposeful behavior.
(C) Gradual arrest in orexin/ mouse. Quiet wakeful behavior gives way to gradual arrest onset with transition to non-REM sleep as in (B).
Note, however, the presence of a pre-REM spindle (Chemelli et al., 1999) at arrest onset (solid arrow), rapid transition to atonia with occasional
jerks, and REM sleep EEG shortly after arrest onset. Rocking behavior occurs during REM sleep EEG as in (A). This arrest ends suddenly
after vigorous rocking.
(D) Power spectral analysis of EEG by FFT during behavioral arrests compared to normal vigilance states. Panels reflect mean spectra of
designated episodes, generated for each of five mice per genotype, and then averaged again for each genotype. Correlation coefficients (r)
demonstrate the degree to which arrest spectra resemble those of normal sleep/wake states from the same mice.
(E) Automatic behavior in association with a gradual arrest in orexin/ mouse. Semipurposeful motor activity typical of wakefulness (chewing
of food) continues despite the onset of unambiguous non-REM sleep. This prolonged dissociated state continues unabated for 42 s prior to
the sudden termination the episode and the resumption of normal wakefulness. Spectral analysis of EEG during this episode illustrates the
high correlation with normal non-REM sleep in the subject. Similar brief episodes of automatic behavior episodes were observed to interrupt
refeeding periods following food deprivation in orexin/ and OX2R/ mice but never in wild-type mice.
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1999; Dement et al., 1966). In the context of narcolepsy- cataplectic humans, are deficient in orexin peptides
(Ripley et al., 2001a). OX2R/ and orexin/ mice arecataplexy but not other disorders of excessive sleepi-
ness, sleep attacks may also give way rapidly to REM the direct biochemical correlates of these two forms
of narcolepsy. By examining the effects of inactivatingsleep periods (so-called “sleep-onset” REM or SOREM
periods) that can be accompanied by sleep paralysis or these two genes in mice, we have produced a compre-
hensive analysis of the resulting phenotypes under con-hallucinations (Hishikawa and Shimizu, 1995; Nishino
and Mignot, 1997; Roth et al., 1969). Unlike cataplexy, trolled genetic conditions of species and strain, allowing
the contribution of the orexin-OX2R pathway to symp-sleepiness is reduced by psychostimulants such as am-
phetamines, modafinil, and caffeine (Shneerson, 2000). toms of narcolepsy-cataplexy to be dissected at the
molecular genetic level.Gradual arrests in both orexin/ and OX2R/ mice
resemble human sleep attacks in several respects. Un- Using behavioral, pharmacological, and electrophysi-
ological means, we determined that narcolepsy syn-like abrupt arrests, gradual arrests most frequently oc-
cur following inconspicuous activities and quiet waking dromes in orexin- and OX2R-deficient mice appear iden-
tical with respect to fragmentation of vigilance statesperiods rather than vigorous motor activities with a
higher potential for emotional content. Not once were and the inability to sustain wakefulness due to interrup-
tion by sleep periods including non-REM sleep attacks.onsets of gradual arrests observed in association with
preceding gait disturbances or muscle atonia sugges- Similarly, both sporadic and genetic forms of canine
narcolepsy exhibit sleepiness based on increased tend-tive of cataplexy. Unlike normal sleep, however, gradual
arrests lack mouse-specific behavioral features of rest encies to fall asleep and more fragmented wakefulness
patterns (Lucas et al., 1979; Nishino et al., 2000), al-and exhibit a loss of head and neck posture reminiscent
of “nodding off” in sleep-deprived humans and narco- though no direct experimental comparison of sleep be-
tween the two canine models has been reported. Behav-leptic dogs (see below); such events are not observed
in wild-type mice under the same conditions. Like sleep ioral attacks of “drowsiness” associated with “stop
motion” and nodding of the head and neck are observedattacks, the onset of gradual arrests is consistently ac-
companied by non-REM sleep EEG/EMG, and arrests in genetically narcoleptic Dobermans, although these
have not been reliably distinguished from cataplexy byare specifically suppressed by caffeine. In both orexin/
and OX2R/ mice, gradual arrests are occasionally ac- EEG/EMG, possibly due in part to the more staged EEG
patterns of non-REM sleep in canines (S. Nishino, per-companied by semipurposeful automatic behavior
(chewing of food) during non-REM sleep, providing fur- sonal communication). Together, these findings suggest
that excessive sleepiness is a consistent feature of orex-ther evidence of the behavioral abnormality of these
arrests and underscoring the subjective sleepiness of in- and OX2R-deficient forms of narcolepsy in both dogs
and mice. Thus, activation of the OX2R gene regulatesthese mice (Guilleminault et al., 1975). In orexin/ mice,
a large proportion of sleep attacks transitioned prema- the gating of transitions from wakefulness to non-REM
sleep and plays a predominant role in preventing theturely from non-REM sleep to REM sleep. Such rapid
transitions to REM sleep, which resemble the SOREM emergence of sleepiness and sleep attacks.
In contrast, we found important differences in bothepisodes of narcoleptic patients, were observed only
rarely in OX2R/ mice. REM sleep control and pathological manifestations of
REM sleep between orexin- and OX2R-deficient forms
of narcolepsy. Unlike orexin/ mice, individual OX2R/Distinct Narcolepsy Syndromes in Animal Models
Corresponding to that which we have described here in mice only infrequently, if at all, exhibit cataplexy-like
arrests or direct transitions from wakefulness to REMmice, at least two phenotypic forms of narcolepsy have
been reported in canines. Familial narcolepsy has been sleep, and sleep attacks in OX2R/ mice were not asso-
ciated with transitions to REM sleep or atonia. This find-maintained in lines of Doberman pinschers and Labrador
retrievers, while sporadic nonfamilial narcolepsy has ing is not without precedent in dogs: early studies of
narcoleptic Dobermans and Labradors found thesebeen studied to a lesser extent in poodles, beagles, and
other small breeds. Both Doberman and Labrador lines dogs to be 30- to 80-fold less severely affected with
cataplexy than poodles with sporadic narcolepsy thatare now understood to carry null mutations of the OX2R
gene (Hungs et al., 2001; Lin et al., 1999), while sporadi- showed literally hundreds of attacks a day (Baker et al.,
1982; see especially Table 2 of this reference), an effectcally narcoleptic dogs, like the majority of narcoleptic-
Figure 5. Comparison of Vigilance States of Knockout Mice
(A) Representative hypnograms of wild-type, orexin/, and OX2R/ mice over the first 6 hr of the dark phase (19:00 to 01:00) obtained by
concatenating 20 s epoch EEG/EMG stage scores. The height of the horizontal line above baseline indicates the vigilance state of the mouse
at the time (min) from the beginning of the dark phase. Baseline, W, represents periods of wakefulness; N, non-REM sleep; R, REM sleep.
Arrowheads highlight direct transitions from wakefulness to REM sleep. Orexin/ and OX2R/ mice show similar fragmentation of vigilance.
(B) Frequency per day of direct transitions from wakefulness to REM sleep in each genotype. Means and SEM are shown.
(C and D) Hourly amounts (C) and durations (D) of awake, non-REM sleep, and REM sleep states (means and SEM) plotted over the 24 hr
day for each group. Data collapsed over 12 hr light and dark phases are displayed as graph insets. Data for the light and dark phases are
displayed on white and light gray backgrounds, respectively. Wakefulness and non-REM sleep are disrupted to a similar degree in orexin/
and OX2R/ mice, especially during the dark phase. Orexin/ mice consistently show significantly increased REM sleep times during the
dark phase compared to normal mice; OX2R/ mice do not. Significant differences between OX2R/ and wild-type mice: *p  0.05, **p 
0.005. Significant differences between orexin/ and wild-type mice:p 0.05,p 0.005,p 0.0005. Significant differences between
orexin/ and OX2R/ mice: #p  0.05.
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netic background. Indeed, an important role of OX1R
activation in REM sleep control is supported by analysis
of OX1R/ and OX1R/;OX2R/ mice (Y.Y.K. et al., un-
published data) as well as a recent report demonstrating
that a selective OX1R antagonist prevents orexin-A-in-
duced suppressions of REM sleep in rats (Smith et al.,
2003).
OX2R and Histaminergic Substrates
of Wakefulness
The anatomical distribution of the orexin system fits
well with the hypothesis that symptoms of narcolepsy-
cataplexy arise from an imbalance between monoami-
nergic and cholinergic mechanisms (Chemelli et al.,
1999; Hungs and Mignot, 2001). Notably, brain levels
of histamine are specifically reduced in OX2R mutant
Dobermans (Nishino et al., 2001). In addition to direct
cortical and thalamocortical activation, histaminergicFigure 6. Hypothetical Model Depicting the Role of the Orexin Path-
ways in Regulating Transitions among Vigilance States neurons of the TM also send projections to the MPT
Whereas Orexin/ and OX2R/ mice are equally affected with at- where cholinergic and noradrenergic neurons reside,
tacks of non-REM sleep, OX2R/ mice are much less severely af- and microinjection of histamine into MPT promotes
fected with cataplexy, paralysis, and SOREM periods. Intact orexin- wakefulness at the expense of non-REM sleep (Lin et
OX2R signaling provides proper regulation of transitions between
al., 1996). The TM itself receives inhibitory input fromwakefulness and non-REM sleep, thus preventing non-REM sleep
sleep-active VLPO and excitatory inputs from wake-attacks. In contrast, both OX2R-dependent and OX2R-independent
active orexin neurons of the LHA (Chemelli et al., 1999;mechanisms play critical roles in maintaining normal transitions be-
tween non-REM and REM sleep and preventing transitions from Sherin et al., 1998). In slices, orexin excites TM neurons
wakefulness to REM sleep, which lead to cataplexy and other REM- (Bayer et al., 2001; Eriksson et al., 2001), and i.c.v. orexin
associated symptoms of narcolepsy. Orexin-OX1R signaling may administration to normal rats stimulates hypothalamic
be implicated in such OX2R-independent REM sleep control.
release of histamine (Ishizuka et al., 2002). Moreover,
genetic or pharmacological blockade of histamine sig-
naling eliminates wakefulness induced by i.c.v. orexinpreviously attributed solely to differences in breed and
administration (Bayer et al., 2001; Eriksson et al., 2001;breed size. Notably, Dobermans and Labradors differ
Huang et al., 2001; Yamanaka et al., 2002).from each other in the severity of phenotype despite
We observed that histaminergic neurons of the TMthe functional equivalence of their mutations, with Lab-
express OX2R, that this cell population remains viableradors exhibiting cataplexy only rarely. In terms of other
in the absence of OX2Rs, and that transients of intracel-abnormalities of REM sleep, studies of narcoleptic Dob-
lular calcium evoked by orexin-A are mediated exclu-ermans showed relatively normal patterns of REM sleep
sively by OX2Rs in these cells. Lack of OX2R may there-cyclicity (Nishino et al., 2000), a finding seemingly at
fore lead to relative inhibition of histaminergic TModds with the long accepted view that human narco-
neurons, with reduced and/or unsteady histamine re-lepsy-cataplexy is primarily a disorder of REM sleep
lease, providing an attractive molecular mechanism by(Dement et al., 1966) but consistent with our findings in
which prolonged wakefulness is destabilized in narco-OX2R/ mice.
lepsy. In support of this hypothesis, histamine-deficientTogether, studies of dogs and mice suggest that
histamine decarboxylase knockout (HDC/) mice, likeOX2R inactivation leads to a spectrum of intermediate
narcoleptic mice, are unable to maintain wakefulness innarcolepsy phenotypes in which some animals have
response to behavioral stimuli (Parmentier et al., 2002).only subthreshold abnormalities with respect to detect-
Critically, HDC/ mice exhibit no evidence of cataplexyable changes in REM sleep control. If so, OX2R defi-
or abnormal intrusions of REM sleep. Clearly, orexin-ciency in mice may also resemble features of less under-
dependent REM sleep control is mediated by down-stood human syndromes, including narcolepsy without
stream neurochemical/neuroanatomical substrates othercataplexy and idiopathic hypersomnia, in which CSF
than OX2R-expressing histamine neurons alone.levels of orexin are not absent (Kanbayashi et al., 2002;
Mignot et al., 2002a).
Our findings offer genetic evidence that the processes Conclusions
Orexin/ and OX2R/ mice are phenotypically equiva-that sustain wakefulness by gating transitions to non-
REM sleep versus gating transitions to REM sleep are lent with respect to symptoms of excessive sleepiness,
yet they exhibit distinct narcolepsy syndromes differingat least partly distinct (Figure 6). While stable regulation
of transitions between wakefulness and non-REM sleep in severity with respect to cataplexy and REM sleep
dysregulation. Our molecular genetic model comple-largely depends upon OX2R activation, appropriate con-
trol of REM sleep involves both OX2R-dependent and ments current anatomic models involving the orexin sys-
tem (Chemelli et al., 1999; Hungs and Mignot, 2001;OX2R-independent mechanisms. An intact OX1R signal-
ing pathway in OX2R/ mice (Figure 1C) provides the Kilduff and Peyron, 2000; Saper et al., 2001). Mainte-
nance of wakefulness and normal gating of non-REMsimplest explanation for the distinct narcolepsy pheno-
types observed within a given species of the same ge- sleep by orexin requires intact OX2R signaling, in part
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treated with 1% sodium borohydrate (Sigma) in DEPC-PBS for 15through the activation of the OX2R-expressing hista-
min at room temperature. After washing in DEPC-PBS, sectionsmine neurons of the TM. Normal regulation of REM sleep
were rinsed in 0.1 M TEA (pH 8.0) and incubated in 0.25% aceticprobably relies not only upon OX2R activation, but also
anhydrate in 0.1 M TEA for 10 min. Sections were rinsed and incu-
upon other signaling pathways such as those mediated bated in hybridization cocktail containing rat probe OX2R.1 (Marcus
by OX1R in locus coeruleus and related mesopontine et al., 2001) for 12–16 hr at 57	C. Posthybridization washes are
as described (Yamamoto et al., 2002), with the addition of threestructures implicated in the gating and generation of
stringency washes in 50% formamide in 0.2
 SSC at 50	C. SectionsREM sleep-related phenomena. We predict that ago-
were then washed in PBS thoroughly and processed for immunohis-nists of each of the orexin receptors, once developed,
tochemistry using DAB as a chromogen.will provide selective therapeutic benefit in the treatment
Dual-label -galactosidase/immunohistochemistry was per-
of specific symptoms of narcolepsy-cataplexy and other formed on mouse brain sections which were rinsed three times for
disorders of sleep and wakefulness. 30 min in 2 mM magnesium chloride, 0.01% sodium deoxycholate,
0.02% NP-40, and then stained for 12–16 hr in 5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide, and 1 mg/ml X-gal inExperimental Procedures
rinsing buffer at room temperature in the dark. Sections were then
rinsed in 10% Formalin, rinsed in PBS, and then stained for ADA asTargeting Vector Construction
described (Chemelli et al., 1999).Murine OX2R gene sequences were cloned from a mouse genomic
library (Stratagene) based on homology to rat sequence (Sakurai et
al., 1998). Restriction mapping, oligonucleotide hybridization, and Northern Blots
sequencing confirmed that overlapping phage clones contained Poly(A)-rich RNA was prepared from RNA (isolated by standard
exon 1. Targeting vector construction was based on a universal procedures) of freshly isolated mouse brains (three mice pooled
nlacZ-neo-tk (pN-Z-TK2) template plasmid vector (Chemelli et al., per genotype of each line) by fractionation with oligo-(dT) cellulose
1999). Exon 1 was replaced in-frame with the nlacZ cassette using columns (Gibco). RNA samples were electrophoresed (7 g/well)
subcloned proximal and distal flanking genomic sequences (see and transferred to nitrocellulose membranes in triplicate. Mem-
Figure 1A). Sequencing confirmed correct insertion of the long and branes were hybridized with cDNA probes containing prepro-orexin,
short arms, as well as in-frame insertion of the nlacZ cassette. The OX2R exon 3, or OX1R exon 3, using standard procedures. After
targeting vector was linearized at a unique AscI site external to the phosphorimaging, membranes were stripped and rehybridized with
3 tk cassette for ES cell transfection. a -actin probe. Semiquantitative comparison was performed by
phosphorimager analysis.
Production of OX2R Knockout Mice
Culture of SM-1 mouse ES cells (129/Sv), electroporation with tar- Orexin Radioimmunoassays
geting vector, and selection for double resistance to G418 and FIAU Whole-brain extracts (excluding cerebellum and pituitary) from 11-
are as described (Chemelli et al., 1999). Double resistant clones to 12-week-old males (six per genotype) were prepared, and RIA
were screened by PCR amplification with primers corresponding to procedures were performed as described (Mondal et al., 1999), using
5 genomic sequence (CTGTGACTTAAGTCCATAGTAGGC) and the antisera specific for orexin-A and -B and lacking detectable cross-
3 nLacZ cassette (GGTTTTCCCAGTCACGACGTTGTA). Correct tar- reactivity.
geting was confirmed by Southern blotting using a flanking 3 geno-
mic probe external to the targeted sequence. Two clones were Intracellular Calcium Imaging
microinjected into C57BL/6J blastocysts, with the production of Intracellular calcium transients evoked by superfusion of orexin-A
germline transmitting chimeric mice as described (Chemelli et al., (300 nM; Sigma) or single droplet application of L-Glutamate (10
1999). OX2R progeny were genotyped by PCR using a common 5 mM; added to chamber inflow) were measured from TM cells in
primer to genomic sequence (AGTCGCGGCGGCGCAGCCTTTCCC) coronal brain slices (250 m sections through the area correspond-
and 3 primers to exon 1 (AATCCTTCTAGAGATCCCTCCTAG) or ing to –2.70 to –2.46 mm from bregma, according to a mouse stereo-
nLacZ (as above). taxic atlas [Franklin and Paxinos, 1997]) from 6- to 13-day-old wild-
type (n  2, C57BL/6 Charles River Labs, NY) or OX2R/ mice
Breeding and Maintenance of Mice (n  2). Slices were prepared and loaded with fura-2 AM (Molecular
Experiments with two independent OX2R and four independent ore- Probes, 15 M) for 30–45 min at 36	C and then rinsed and imaged
xin knockout lines (Chemelli et al., 1999), including littermate con- in normal oxygenated artificial CSF (containing, in mM: NaCl, 121;
trols, were concurrently performed using male F2 and F3 genera- KCl, 5; Na2PO4; 1.2, CaCl2, 2.7, MgSO4, 1.2, NaHCO3, 26, dextrose,
tions (produced from crosses of F1 and F2 heterozygotes) on a 20; pH 7.4) as described (K.K.A., T. Inoue, and L.C.S., submitted).
C57BL/6J-129/SvEv mixed background. Mice were provided food Changes in [Ca2]i were inferred from changes in fura-2 fluorescence
and water ad lib (except where noted below), maintained on a 12 (510 nm emission; 380 nm excitation) and measured as F/F from
hr light:dark cycle at all times, and were housed under conditions background subtracted images.
that controlled temperature and humidity. All procedures were ap-
proved by the appropriate institutional animal care and use commit- Infrared Video Characterization of Narcoleptic Behavior
tees and were carried out in strict accordance with NIH guidelines. CCD video cameras (8 mm format Sony TRV-CCD66 and mini-DV
format DCR-TRV8) with infrared and digital time recording capabili-
ties were used to document behavior (4 hr/mouse) using a standardHistological Studies
In situ hybridization was performed with probes corresponding to open field apparatus (Opto-Varimex-3, Columbus Instruments, Co-
lumbus, OH) as described previously (Chemelli et al., 1999). Micemouse OX2R exon 3, which was determined by 3 RACE from exon
2 (see above), amplified by PCR using primers ACAGACTGTGT had free access to food and water throughout the experiments.
The criteria for scoring abrupt arrests included (1) an abrupt (lessCAGTGTCTGTG and GCCCCAGTGTTCATCACATAC, and cloned
into pCRII-TOPO (Invitrogen) in sense and antisense orientations. than 1–2 s) transition from obvious, generally robust, purposeful
motor activity; (2) a sustained collapsed posture maintainedBrains were sectioned, riboprobes were generated, and hybridiza-
tion was performed as described (Chemelli et al., 1999). throughout the episode; and (3) an abrupt end to the episode with
resumption of obvious purposeful motor activity. Criteria for gradualDual-label in situ hybridization/immunohistochemistry in rat was
performed by a modified protocol similar to that described pre- arrests are identical except for a gradual (2 s) onset with transition
from obvious, generally quiet, purposeful motor activity. Gradualviously (Elias et al., 1998). Brain sections (30 m) were first pro-
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